column
Select articles
Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus (2020 edition)
Chinese Association of Liver Cancer, Chinese Medical Doctor Association, Cheng Shuqun, Chen Minshan, Cai Jianqiang
2021, 20(2): 135-142. DOI: 10.3760/cma.j.cn115610-20210208-00068
Abstract PDF
Application of robotic surgical system in hepatic surgery
Zhang Wei, Chen Xiaoping
2021, 20(2): 143-148. DOI: 10.3760/cma.j.cn115610-20210120-00035
Abstract PDF
Fluorescence guidance in digestive surgery
Thornblade Lucas Willian, Melstrom Kurt Allan, Zhumkhawala Ali, Fong Yuman
2021, 20(2): 149-154. DOI: 10.3760/cma.j.cn115610-20201126-00740
Abstract PDF
Advances of associating liver partition and portal vein ligation for staged hepatectomy in the treatment of primarilly unresectable liver cancer
Peng Yuanfei, Wang Zheng, Zhou Jian
2021, 20(2): 155-162. DOI: 10.3760/cma.j.cn115610-20201224-00801
Abstract PDF
Progress and hot spots of comprehensive treatment for primary liver cancer
Yuan Shengxian, Zhou Weiping
2021, 20(2): 163-170. DOI: 10.3760/cma.j.cn115610-20201211-00776
Abstract PDF
Research progress of hepatic arterial infusion chemotherapy in the conversion therapy of hepatocellular carcinoma
Chen Minshan, Hu Zili
2021, 20(2): 171-177. DOI: 10.3760/cma.j.cn115610-20201230-00813
Abstract PDF
Challenges and tactics of laparoscopic anatomical hepatectomy of segment 7
Li Yunfeng, Yin Xinmin
2021, 20(2): 178-183. DOI: 10.3760/cma.j.cn115610-20201222-00796
Abstract PDF
Progress and consideration of immunotherapy strategy for hepatocellular carcinoma
Liang Jun, Li Li
2021, 20(2): 184-190. DOI: 10.3760/cma.j.cn115610-20201228-00809
Abstract PDF
Evidence-based medicine proof and development trends of first-line treatment for advanced hepatocellular carcinoma
Zhao Ming, Wu Jiaming, Lyu Ning
2021, 20(2): 191-196. DOI: 10.3760/cma.j.cn115610-20201215-00784
Abstract PDF
Clinical efficacy of combination therapy with lenvatinib and programmed death-1 antibodies in unresectable or advanced hepatocellular carcinoma
Xu Bin, Zhu Xiaodong, Huang Cheng, Shen Yinghao, Zhu Jinjin, Li Meiling, Liu Jie, Zhou Jian, Fan Jia, Sun Huichuan
2021, 20(2): 197-204. DOI: 10.3760/cma.j.cn115610-20201217-00791
Abstract PDF
Prognostic value of preoperative red blood cell distribution width for hepatocellular carcinoma
Long Yunxiang, Qu Kai, Zhang Jingyao, Wang Zhixin, Wang Haijiu, Fan Haining, Li Yiming, Liu Chang, Lin Ting
2021, 20(2): 205-212. DOI: 10.3760/cma.j.cn115610-20210111-00014
Abstract PDF
Prognostic value of preoperative inflammatory indicators for hepatocellular carcinoma
Wu Meilong, Yang Shizhong, Feng Xiaobin, Yu Fei, Dong Jiahong
2021, 20(2): 213-219. DOI: 10.3760/cma.j.cn115610-20210125-00041
Abstract PDF
Analysis of influencing factors for synchronous colorectal liver metastasis: a report of 3 172 cases
Tian Chuanxin, Cao Jingyu, Chen Yu, Ma Zhao, Zhao Lei
2021, 20(2): 220-226. DOI: 10.3760/cma.j.cn115610-20210114-00023
Abstract PDF
Application value of hepatic vein outflow tract reconstruction with ringed polytetrafluoroe-thylene vascular in right lobe living donor liver transplantation
Sun Beicheng, Mu Xiaoxin, Li Guoqiang, Wu Chen, Tan Zhongming
2021, 20(2): 227-233. DOI: 10.3760/cma.j.cn115610-20201124-00738
Abstract PDF
Surgical treatment for compression of inferior vena cava by hepatic hydatid cyst
Zhang Hongwei, Wu Xiangwei, Zhang Shijie, Abuduwayiti, Sun Hong, Peng Xinyu
2021, 20(2): 234-239. DOI: 10.3760/cma.j.cn115610-20210112-00018
Abstract PDF
Application value of spectral CT multi‑parameter imaging in predicting gastric cancer lymph node metastasis
Chai Yaru, Gao Jianbo, Yue Songwei, Zhang Yonggao, Lyu Peijie, Xing Jingjing, Chen Yan, Liang Pan, Liu Jie
2021, 20(2): 240-245. DOI: 10.3760/cma.j.cn115610-20210104-00002
Abstract PDF
Diagnosis and treatment for rupture and bleeding of accessory hepatic aneurysms
Lu Zengxin, Zhou Jianwei, Kong Jianguo, Luo Zhouye
2021, 20(2): 246-249. DOI: 10.3760/cma.j.cn115610-20210109-00012
Abstract PDF
Research advances of immune checkpoint inhibitors in the treatment of cholangiocarcinoma
Chang Jiang, Gu Yichao, Li Xiangcheng
2021, 20(2): 250-254. DOI: 10.3760/cma.j.cn115610-20210122-00037
Abstract PDF